300453 三鑫医疗
未开盘 08-11 09:30:00
资讯
新帖
简况
股市必读:三鑫医疗新发布《向不特定对象发行可转换公司债券发行结果公告》
证券之星 · 08-10 02:43
股市必读:三鑫医疗新发布《向不特定对象发行可转换公司债券发行结果公告》
股市必读:三鑫医疗新发布《向不特定对象发行可转换公司债券网上发行中签率及优先配售结果公告》
证券之星 · 08-06
股市必读:三鑫医疗新发布《向不特定对象发行可转换公司债券网上发行中签率及优先配售结果公告》
三鑫医疗(300453)披露向不特定对象发行可转换公司债券网上发行中签率及优先配售结果公告,8月4日股价下跌2.24%
证券之星 · 08-04
三鑫医疗(300453)披露向不特定对象发行可转换公司债券网上发行中签率及优先配售结果公告,8月4日股价下跌2.24%
三鑫医疗(300453)披露向不特定对象发行可转换公司债券发行提示性公告,8月3日股价上涨0.82%
证券之星 · 08-03
三鑫医疗(300453)披露向不特定对象发行可转换公司债券发行提示性公告,8月3日股价上涨0.82%
研报掘金丨国盛证券:首予三鑫医疗“买入”评级,国产替代与新品放量正当时
格隆汇 · 08-03
研报掘金丨国盛证券:首予三鑫医疗“买入”评级,国产替代与新品放量正当时
股市必读:三鑫医疗新发布《第六届董事会第二次会议决议公告》
证券之星 · 08-03
股市必读:三鑫医疗新发布《第六届董事会第二次会议决议公告》
股市必读:三鑫医疗(300453)新发布《第六届董事会第二次会议决议公告》
证券之星 · 07-31
股市必读:三鑫医疗(300453)新发布《第六届董事会第二次会议决议公告》
三鑫医疗(300453)披露向不特定对象发行可转换公司债券发行公告,7月30日股价上涨0.52%
证券之星 · 07-30
三鑫医疗(300453)披露向不特定对象发行可转换公司债券发行公告,7月30日股价上涨0.52%
三鑫医疗获得实用新型专利授权:“一种用于血液体外密闭循环装置”
证券之星 · 07-28
三鑫医疗获得实用新型专利授权:“一种用于血液体外密闭循环装置”
三鑫医疗最新公告:控股子公司人工血管产品进入创新医疗器械特别审查程序
证券之星 · 07-16
三鑫医疗最新公告:控股子公司人工血管产品进入创新医疗器械特别审查程序
三鑫医疗(300453)披露控股子公司变更医疗器械生产许可证公告,7月13日股价上涨0.43%
证券之星 · 07-13
三鑫医疗(300453)披露控股子公司变更医疗器械生产许可证公告,7月13日股价上涨0.43%
三鑫医疗:6月9日彭义兴、雷凤莲增持股份合计34.62万股
证券之星 · 06-09
三鑫医疗:6月9日彭义兴、雷凤莲增持股份合计34.62万股
三鑫医疗(300453.SZ)发行可转债申请获证监会同意注册批复
智通财经 · 06-05
三鑫医疗(300453.SZ)发行可转债申请获证监会同意注册批复
三鑫医疗:应用于血液透析器的医用聚醚砜(PES)材料国产化制备技术及产业化研究
证券之星 · 05-29
三鑫医疗:应用于血液透析器的医用聚醚砜(PES)材料国产化制备技术及产业化研究
三鑫医疗(300453)披露2025年年度权益分派实施公告,5月21日股价下跌2.21%
证券之星 · 05-21
三鑫医疗(300453)披露2025年年度权益分派实施公告,5月21日股价下跌2.21%
三鑫医疗新注册《双联机干粉血液透析设备治疗控制系统V1.0》项目的软件著作权
证券之星 · 05-21
三鑫医疗新注册《双联机干粉血液透析设备治疗控制系统V1.0》项目的软件著作权
三鑫医疗(300453)披露选举第六届董事会职工代表董事公告,5月15日股价下跌1.97%
证券之星 · 05-15
三鑫医疗(300453)披露选举第六届董事会职工代表董事公告,5月15日股价下跌1.97%
三鑫医疗(300453)披露向不特定对象发行可转换公司债券募集说明书(注册稿),5月13日股价下跌0.68%
证券之星 · 05-13
三鑫医疗(300453)披露向不特定对象发行可转换公司债券募集说明书(注册稿),5月13日股价下跌0.68%
每周股票复盘:三鑫医疗(300453)Q1净利增27.23%,“湿膜”透析器进集采
证券之星 · 05-03
每周股票复盘:三鑫医疗(300453)Q1净利增27.23%,“湿膜”透析器进集采
三鑫医疗(300453)披露将参加江西辖区上市公司2026年投资者网上集体接待日活动,4月30日股价下跌2.04%
证券之星 · 04-30
三鑫医疗(300453)披露将参加江西辖区上市公司2026年投资者网上集体接待日活动,4月30日股价下跌2.04%
加载更多
公司概况
公司名称:
江西三鑫医疗科技股份有限公司
所属行业:
专用设备制造业
上市日期:
2015-05-15
主营业务:
江西三鑫医疗科技股份有限公司的主营业务是医疗器械研发、制造、销售和服务。公司的主要产品是血液透析设备、血液透析制水系统、一次性使用血液透析器、血液透析浓缩液、血液透析粉、一次性使用血液透析管路、一次性使用透析用留置针、透析液过滤器、一次性使用机用采血器、血液透析设备、血液透析滤过器、血液净化补液管路、连续性血液净化管路及附件。公司荣获“国家工信部智能制造优秀场景”“江西省智能制造标杆企业”“5G+工业互联网”应用示范项目等多项权威荣誉,标杆地位获得广泛认可。
发行价格:
12.87
{"stockData":{"symbol":"300453","market":"SZ","secType":"STK","nameCN":"三鑫医疗","latestPrice":9.71,"timestamp":1786410366000,"preClose":9.71,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":360000000,"shares":522000000,"eps":0.5355,"marketStatus":"未开盘","change":0,"latestTime":"08-11 09:30:00","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0.5355,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786411800000},"marketStatusCode":0,"adr":0,"adjPreClose":9.71,"symbolType":"stock","openAndCloseTimeList":[[1786411800000,1786419000000],[1786424400000,1786431600000]],"highLimit":10.68,"lowLimit":8.74,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":522084275,"isCdr":false,"pbRate":3.32,"roa":"--","peRate":18.132586,"roe":"5.03%","epsLYR":0.5117,"committee":0,"marketValue":5069000000,"turnoverRate":0,"status":2,"floatMarketCap":3494000000},"requestUrl":"/m/hq/s/300453","defaultTab":"news","newsList":[{"id":"2658529608","title":"股市必读:三鑫医疗新发布《向不特定对象发行可转换公司债券发行结果公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2658529608","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658529608?lang=zh_cn&edition=full","pubTime":"2026-08-10 02:43","pubTimestamp":1786300990,"startTime":"0","endTime":"0","summary":"公司公告汇总:三鑫医疗向不特定对象发行可转债53,000.00万元,“三鑫转债”完成发行,原股东优先配售占比85.24%,主承销商包销比例0.12%。公司公告汇总向不特定对象发行可转换公司债券发行结果公告江西三鑫医疗科技股份有限公司向不特定对象发行可转换公司债券已获中国证监会注册同意,本次发行可转债简称为“三鑫转债”,代码为“123280”,发行总额为53,000.00万元,每张面值100元,共5,300,000张。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000001175.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300453"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657524843","title":"股市必读:三鑫医疗新发布《向不特定对象发行可转换公司债券网上发行中签率及优先配售结果公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657524843","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657524843?lang=zh_cn&edition=full","pubTime":"2026-08-06 02:00","pubTimestamp":1785952850,"startTime":"0","endTime":"0","summary":"公司公告汇总:三鑫医疗向不特定对象发行可转债53,000.00万元,网上中签率0.0007517747%,中签号码共78,241个,每个可认购10张。公司公告汇总向不特定对象发行可转换公司债券网上发行中签率及优先配售结果公告江西三鑫医疗科技股份有限公司向不特定对象发行可转换公司债券,发行总额为53,000.00万元,每张面值100元,共计5,300,000张。原股东优先配售4,517,586张,占发行总量的85.24%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600001726.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300453","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656552747","title":"三鑫医疗(300453)披露向不特定对象发行可转换公司债券网上发行中签率及优先配售结果公告,8月4日股价下跌2.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656552747","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656552747?lang=zh_cn&edition=full","pubTime":"2026-08-04 22:40","pubTimestamp":1785854425,"startTime":"0","endTime":"0","summary":"截至2026年8月4日收盘,三鑫医疗报收于9.6元,较前一交易日下跌2.24%,最新总市值为50.12亿元。该股当日开盘9.33元,最高9.6元,最低9.29元,成交额达2.06亿元,换手率为6.02%。近日,江西三鑫医疗科技股份有限公司披露《向不特定对象发行可转换公司债券网上发行中签率及优先配售结果公告》。公告显示,本次向不特定对象发行可转换公司债券发行总额为53,000.00万元,每张面值100元,共计5,300,000张。有效申购数量为104,075,057,170张,配号总数为10,407,505,717个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400041702.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300453","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656727933","title":"三鑫医疗(300453)披露向不特定对象发行可转换公司债券发行提示性公告,8月3日股价上涨0.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656727933","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656727933?lang=zh_cn&edition=full","pubTime":"2026-08-03 22:13","pubTimestamp":1785766395,"startTime":"0","endTime":"0","summary":"截至2026年8月3日收盘,三鑫医疗报收于9.82元,较前一交易日上涨0.82%,最新总市值为51.27亿元。该股当日开盘9.71元,最高9.84元,最低9.61元,成交额达1.98亿元,换手率为5.63%。公告显示,公司向不特定对象发行可转换公司债券,发行总额为53,000.00万元,每张面值100元,共计5,300,000张。原股东可优先配售,股权登记日为2026年8月3日,优先配售日与网上申购日为2026年8月4日。本次发行由国金证券余额包销,包销基数为53,000.00万元,最大包销金额为15,900.00万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300036961.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300453"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656827325","title":"研报掘金丨国盛证券:首予三鑫医疗“买入”评级,国产替代与新品放量正当时","url":"https://stock-news.laohu8.com/highlight/detail?id=2656827325","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656827325?lang=zh_cn&edition=full","pubTime":"2026-08-03 14:36","pubTimestamp":1785738996,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["300453","002670","BK0276","BK0251","BK0052"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656234848","title":"股市必读:三鑫医疗新发布《第六届董事会第二次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2656234848","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656234848?lang=zh_cn&edition=full","pubTime":"2026-08-03 01:30","pubTimestamp":1785691828,"startTime":"0","endTime":"0","summary":"公司公告汇总:三鑫医疗向不特定对象发行53,000万元可转换公司债券已获中国证监会注册同意,优先配售股权登记日为2026年8月3日,申购日为8月4日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300000577.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300453","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655005048","title":"股市必读:三鑫医疗(300453)新发布《第六届董事会第二次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2655005048","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655005048?lang=zh_cn&edition=full","pubTime":"2026-07-31 02:26","pubTimestamp":1785435973,"startTime":"0","endTime":"0","summary":"截至2026年7月30日收盘,三鑫医疗报收于9.75元,上涨0.52%,换手率2.23%,成交量8.01万手,成交额7781.02万元。江西华邦律师事务所关于江西三鑫医疗科技股份有限公司向不特定对象发行可转换公司债券的法律意见书出具法律意见书及多份补充法律意见书,确认发行人符合发行条件,相关行为合法有效,不存在重大违法行为,不构成发行障碍。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073100001792.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300453","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655507806","title":"三鑫医疗(300453)披露向不特定对象发行可转换公司债券发行公告,7月30日股价上涨0.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2655507806","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655507806?lang=zh_cn&edition=full","pubTime":"2026-07-30 22:36","pubTimestamp":1785422178,"startTime":"0","endTime":"0","summary":"截至2026年7月30日收盘,三鑫医疗报收于9.75元,较前一交易日上涨0.52%,最新总市值为50.9亿元。该股当日开盘9.69元,最高9.78元,最低9.6元,成交额达7781.02万元,换手率为2.23%。近日,三鑫医疗发布《向不特定对象发行可转换公司债券发行公告》,披露公司向不特定对象发行可转换公司债券,发行总额为53,000.00万元,每张面值100元,共计5,300,000张。原股东可优先配售,股权登记日为2026年8月3日,申购日为2026年8月4日。本次发行不设担保,由国金证券余额包销。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073000040008.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300453"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654005047","title":"三鑫医疗获得实用新型专利授权:“一种用于血液体外密闭循环装置”","url":"https://stock-news.laohu8.com/highlight/detail?id=2654005047","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654005047?lang=zh_cn&edition=full","pubTime":"2026-07-28 03:34","pubTimestamp":1785180882,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示三鑫医疗新获得一项实用新型专利授权,专利名为“一种用于血液体外密闭循环装置”,专利申请号为CN202423267595.5,授权日为2026年7月28日。本实用新型通过将第一透析器接头和第二透析器接头连接至透析器的动脉端和静脉端,通过蠕动泵来进行吸取血液,并利用管夹来控制弹力软管的开关和闭合,以实现密闭操作,可显著减少外部因素对血液造成的影响,有效避免血液接触空气引起的实验误差,提高试验可靠性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072800003054.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300453"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651450444","title":"三鑫医疗最新公告:控股子公司人工血管产品进入创新医疗器械特别审查程序","url":"https://stock-news.laohu8.com/highlight/detail?id=2651450444","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651450444?lang=zh_cn&edition=full","pubTime":"2026-07-16 18:51","pubTimestamp":1784199072,"startTime":"0","endTime":"0","summary":"三鑫医疗(300453.SZ)公告称,近日,公司控股子公司江西钶维肽生物科技有限公司自主研发的人工血管产品获得国家药监局医疗器械技术审评中心同意,进入创新医疗器械特别审查程序。进入创新医疗器械特别审查程序的创新医疗器械产品,在注册申报时可享受优先办理的权益,药品监督管理部门及相关技术机构将按照早期介入、专人负责、科学审查的原则,在标准不降低、程序不减少的前提下进行审评审批。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600032911.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300453","BK0251","09996","BK1574","BK1583","159883","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651922110","title":"三鑫医疗(300453)披露控股子公司变更医疗器械生产许可证公告,7月13日股价上涨0.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651922110","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651922110?lang=zh_cn&edition=full","pubTime":"2026-07-13 22:40","pubTimestamp":1783953623,"startTime":"0","endTime":"0","summary":"截至2026年7月13日收盘,三鑫医疗报收于9.39元,较前一交易日上涨0.43%,最新总市值为49.02亿元。近日,三鑫医疗披露《关于控股子公司变更医疗器械生产许可证的公告》。公告显示,公司控股子公司成都威力生生物科技有限公司因生产经营需要,变更了《医疗器械生产许可证》的生产地址,并取得四川省药品监督管理局换发的新证。本次变更不涉及实质性经营变化,不会对公司生产经营产生重大影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071300040755.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09996","BK1574","BK1100","BK0251","300453","159883","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642467547","title":"三鑫医疗:6月9日彭义兴、雷凤莲增持股份合计34.62万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2642467547","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2642467547?lang=zh_cn&edition=full","pubTime":"2026-06-09 20:01","pubTimestamp":1781006496,"startTime":"0","endTime":"0","summary":"证券之星消息,根据6月9日市场公开信息、上市公司公告及交易所披露数据整理,三鑫医疗(300453)最新董监高及相关人员股份变动情况:2026年6月9日公司董事长彭义兴、副董事长雷凤莲共增持公司股份34.62万股,占公司总股本为0.0663%。变动期间公司股价上涨1.02%,6月9日当日收盘报8.9元。三鑫医疗近半年内的董监高及核心技术人员增减持详情如下:三鑫医疗的高管列表及最新持股情况如下:该股最近90天内无机构评级。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060900035148.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300453"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641119663","title":"三鑫医疗(300453.SZ)发行可转债申请获证监会同意注册批复","url":"https://stock-news.laohu8.com/highlight/detail?id=2641119663","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2641119663?lang=zh_cn&edition=full","pubTime":"2026-06-05 17:20","pubTimestamp":1780651249,"startTime":"0","endTime":"0","summary":"智通财经APP讯,三鑫医疗(300453.SZ)发布公告,公司于近日收到中国证监会出具的《关于同意江西三鑫医疗科技股份有限公司向不特定对象发行可转换公司债券注册的批复》(证监许可[2026]1311号),同意公司向不特定对象发行可转换公司债券的注册申请。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450739.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","300453"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639361773","title":"三鑫医疗:应用于血液透析器的医用聚醚砜(PES)材料国产化制备技术及产业化研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2639361773","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2639361773?lang=zh_cn&edition=full","pubTime":"2026-05-29 08:45","pubTimestamp":1780015513,"startTime":"0","endTime":"0","summary":"公司作为牵头单位的“应用于血液透析器的医用聚醚砜材料国产化制备技术及产业化研究”入选为国家工信部生物医用材料创新任务揭榜挂帅项目,项目实施以来进展顺利,已进入测试验证阶段,主要技术性能指标达到预期要求。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052900008498.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300453"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637382150","title":"三鑫医疗(300453)披露2025年年度权益分派实施公告,5月21日股价下跌2.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637382150","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2637382150?lang=zh_cn&edition=full","pubTime":"2026-05-21 18:25","pubTimestamp":1779359118,"startTime":"0","endTime":"0","summary":"截至2026年5月21日收盘,三鑫医疗报收于9.74元,较前一交易日下跌2.21%,最新总市值为50.85亿元。公司于当日披露《2025年年度权益分派实施公告》。公告显示,江西三鑫医疗科技股份有限公司2025年年度权益分派方案为:以总股本剔除回购股份后的521,924,275股为基数,向全体股东每10股派发现金红利2.00元(含税),共计派发现金红利104,384,855元(含税)。本次权益分派股权登记日为2026年5月27日,除权除息日为2026年5月28日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100036467.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300453","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637822824","title":"三鑫医疗新注册《双联机干粉血液透析设备治疗控制系统V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2637822824","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2637822824?lang=zh_cn&edition=full","pubTime":"2026-05-21 01:53","pubTimestamp":1779299592,"startTime":"0","endTime":"0","summary":"证券之星消息,近日三鑫医疗新注册了《双联机干粉血液透析设备治疗控制系统V1.0》项目的软件著作权。今年以来三鑫医疗新注册软件著作权3个,较去年同期增加了200%。结合公司2025年年报财务数据,2025年公司在研发方面投入了7527.95万元,同比增17.66%。通过天眼查大数据分析,江西三鑫医疗科技股份有限公司共对外投资了15家企业,参与招投标项目852次;财产线索方面有商标信息65条,专利信息239条,著作权信息9条;此外企业还拥有行政许可177个。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100002187.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","159180","300453"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635070967","title":"三鑫医疗(300453)披露选举第六届董事会职工代表董事公告,5月15日股价下跌1.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635070967","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2635070967?lang=zh_cn&edition=full","pubTime":"2026-05-15 17:29","pubTimestamp":1778837363,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘,三鑫医疗报收于9.97元,较前一交易日下跌1.97%,最新总市值为52.05亿元。公告显示,江西三鑫医疗科技股份有限公司于2026年5月14日召开职工代表大会,选举曾美花女士为第六届董事会职工代表董事。第六届董事会由9名董事组成,其中1名职工代表董事,任期自2025年年度股东会审议通过之日起三年。本次选举后,公司董事会中兼任高管及职工代表董事人数未超过半数,符合相关规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500031847.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300453","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635420043","title":"三鑫医疗(300453)披露向不特定对象发行可转换公司债券募集说明书(注册稿),5月13日股价下跌0.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635420043","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2635420043?lang=zh_cn&edition=full","pubTime":"2026-05-13 17:58","pubTimestamp":1778666321,"startTime":"0","endTime":"0","summary":"截至2026年5月13日收盘,三鑫医疗报收于10.26元,较前一交易日下跌0.68%,最新总市值为53.57亿元。该股当日开盘10.3元,最高10.46元,最低10.22元,成交额达1.29亿元,换手率为3.49%。公司于近日披露《江西三鑫医疗科技股份有限公司向不特定对象发行可转换公司债券募集说明书(注册稿)》。公告同时指出,公司2023至2025年度累计现金分红占年均净利润比例达167.26%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300033361.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300453"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632677708","title":"每周股票复盘:三鑫医疗(300453)Q1净利增27.23%,“湿膜”透析器进集采","url":"https://stock-news.laohu8.com/highlight/detail?id=2632677708","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2632677708?lang=zh_cn&edition=full","pubTime":"2026-05-03 06:15","pubTimestamp":1777760117,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘,三鑫医疗报收于10.08元,较上周的10.05元上涨0.3%。本周,三鑫医疗4月27日盘中最高价报10.49元。本周关注点来自业绩披露要点:2026年第一季度净利润同比增长27.23%。来自机构调研要点:“湿膜”透析器进入二十三省接续采购中选目录。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300001477.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300453"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631557546","title":"三鑫医疗(300453)披露将参加江西辖区上市公司2026年投资者网上集体接待日活动,4月30日股价下跌2.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631557546","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2631557546?lang=zh_cn&edition=full","pubTime":"2026-04-30 22:13","pubTimestamp":1777558396,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘,三鑫医疗报收于10.08元,较前一交易日下跌2.04%,最新总市值为52.63亿元。该股当日开盘10.24元,最高10.28元,最低9.97元,成交额达1.91亿元,换手率为5.26%。近日,三鑫医疗披露《关于参加江西辖区上市公司2026年投资者网上集体接待日活动的公告》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000068733.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300453"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1786410395710,"stockEarnings":[{"period":"1week","weight":-0.0112},{"period":"1month","weight":0.0385},{"period":"3month","weight":-0.0398},{"period":"6month","weight":0.0475},{"period":"1year","weight":0.1073},{"period":"ytd","weight":0.1375}],"compareEarnings":[{"period":"1week","weight":0.0412},{"period":"1month","weight":-0.0074},{"period":"3month","weight":-0.0588},{"period":"6month","weight":-0.04},{"period":"1year","weight":0.0912},{"period":"ytd","weight":-0.0006}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江西三鑫医疗科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"21545人(较上一季度增加0.44%)","perCapita":"16702股","listingDate":"2015-05-15","address":"江西省南昌市南昌县小蓝经济开发区富山大道999号","registeredCapital":"52208万元","survey":" 江西三鑫医疗科技股份有限公司的主营业务是医疗器械研发、制造、销售和服务。公司的主要产品是血液透析设备、血液透析制水系统、一次性使用血液透析器、血液透析浓缩液、血液透析粉、一次性使用血液透析管路、一次性使用透析用留置针、透析液过滤器、一次性使用机用采血器、血液透析设备、血液透析滤过器、血液净化补液管路、连续性血液净化管路及附件。公司荣获“国家工信部智能制造优秀场景”“江西省智能制造标杆企业”“5G+工业互联网”应用示范项目等多项权威荣誉,标杆地位获得广泛认可。","listedPrice":12.87},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三鑫医疗(300453)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三鑫医疗(300453)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三鑫医疗,300453,三鑫医疗股票,三鑫医疗股票老虎,三鑫医疗股票老虎国际,三鑫医疗行情,三鑫医疗股票行情,三鑫医疗股价,三鑫医疗股市,三鑫医疗股票价格,三鑫医疗股票交易,三鑫医疗股票购买,三鑫医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三鑫医疗(300453)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三鑫医疗(300453)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}